Document Migration
PRODUCTS
-
The MXPD70 (“Multicoax Precision Direct”) series is a miniaturized, solderless multicoax test solution designed to address two key trends in the semiconductor industry: cost efficiency and height restrictions.
-
We update our used pharmaceutical process manufacturing equipment inventory daily, host used pharmaceutical equipment auctions weekly, organize pharmaceutical equipment liquidations, and pharmaceutical private treaty equipment sales.
-
For your efficient and error-proof production: Our world-leading Manufacturing Execution System (MES) Suite PAS-X controls, monitors, and documents your processes digitally and in real time throughout the entire manufacturing cycle.
-
Our RegOps team offers document-level publishing or management of the entire regulatory submission process. Coupled with our electronic document management system (Veeva), we can oversee all technical aspects for submission of your dossier (eg, eCTD document granularity, utilization of content templates, document formatting, hyperlinking, bookmarks, navigation, publishing, and redaction services).
-
LMD 6 Laser Microdissection Microscope
Dissection Perfection
Laser Microdissection (LMD, also known as Laser Capture Microdissection or LCM) enables users to isolate specific single cells or entire areas of tissue. Powered by a unique laser design and dynamic software, Leica LMD systems allow users to easily isolate Regions of Interest (ROI) from entire areas of tissue down to single cells or even subcellular structures such as chromosomes.
LMD is typically used in genomics (DNA), transcriptomics (mRNA, miRNA), proteomics, metabolomics, and even next generation sequencing (NGS). Researchers in neurology, cancer research, plant analysis, forensics or climate research rely on this method. Furthermore, LMD is a perfect tool for live cell culture (LCC), for cloning and re-cultivation, manipulation or downstream analysis.
We move the laser, not the sample. And we use gravity for collection. That is why our LMD systems provide you with perfectly cut, contamination-free, analysis-ready dissectates.
WHITE PAPERS AND CASE STUDIES
-
Sustainable Solutions For Medical Devices
Explore how medical device companies aim to balance patient safety with environmental stability by offering bio-based UHMWPE, which reduces carbon footprints by up to 70%.
-
Future-Proofing Life Sciences Manufacturing: 2025 CDMO Trends
Review contract manufacturing's evolution, driven by technological advancements and regulatory changes, and how CMOs and CDMOs are navigating opportunities and challenges.
-
From CLD To CDMO: Demonstrating A Successful Cell Line Technology Transfer
Explore critical considerations for biopharmaceutical developers and CDMOs during technology transfer as well as a successful transfer and scale-up of a cell line from a CLD platform to a global CDMO.
-
Achieving Excellence In Clinical Research And Quality Management
Lotus Clinical Research, founded in 2001, leverages regulatory expertise and digitalization to enhance quality, automate processes, and improve compliance in biopharmaceutical clinical trials.
-
5 Essential Capabilities For Decentralized Clinical Trials
Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.
-
Increasing Batch Size And Reducing Cycle Times For A Biologic
JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.
-
Patient Perspectives On eConsent
Explore how eConsent enables participants to engage meaningfully with consent documentation, addressing information dissemination, explanation, and recall challenges.
-
Achieving Faster Timelines And Cost Savings Through Digital Validation
Examine how the Project Ready program was leveraged to streamline validation processes for a CDMO, resulting in a 25% reduction in budget and faster project completion.
-
The Role Of The Technical Transfer Executive Sponsor
Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical capabilities, regulatory support, quality system, and executive sponsorship model.
-
Transforming Environmental Monitoring And Sample Management
Discover how applying an OpEx framework to environmental monitoring and sample management can optimize workflows, improve resource utilization, and deliver measurable annual cost savings.
-
CRO Collaboration That Fuels Innovation For Specialty Biotechs
Delve into the advantages of specialty CRO collaborations and the strategic opportunities that lie ahead as the life sciences field continues to embrace innovation and collaboration.
-
Building A Legacy In Sterile Injectables Through Strong CMO Synergy
Examine how a CMO can deliver significant value to drug developers by fostering successful outsourcing relationships, streamlining the path to market, and supporting demands.
NEWS
-
WAGO And Radiflow Join Forces To Strengthen OT Security For Customers5/28/2024
WAGO and Radiflow enter into a partnership and combine their competencies in the future. Together, they aim to strengthen resilience against potential cyber threats and make the OT networks of critical infrastructure and industrial environments as secure as possible.
-
ZEISS And Argolight Announce Partnership To Enhance Microscopy Imaging Quality Control4/23/2024
Today, ZEISS and Argolight announced their strategic partnership.
-
BlueFletch Pioneers Integration With Microsoft's QR Code + PIN Authentication For Frontline Workers2/25/2025
BlueFletch, a leading provider of secure enterprise mobility solutions, announces its pioneering integration with Microsoft's QR Code + PIN authentication method.
-
Positon AI Unveils Groundbreaking AI-Powered Legal Document Management Feature9/3/2024
Positon AI, a leader in artificial intelligence solutions for the financial and legal sectors, is thrilled to announce the launch of its new AI-powered legal document management feature.
-
A New Era Of AI-Driven Information Management7/22/2025
OpenText™ (NASDAQ: OTEX), (TSX: OTEX) today announced today announced the launch of its Cloud Editions (CE) 25.3, a major release that redefines how organizations harness the power of AI, cloud, and cybersecurity to drive business outcomes.